Franklin Street Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Franklin Street Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-29,001	Closed	-$1.33M	–	179
2016 Q3	$1.33M	Sell	29,001 -432	-1%	-$22.5K	0.24%	91
2016 Q2	$1.48M	Buy	29,433 +82	+0.3%	+$4.37K	0.28%	85
2016 Q1	$1.57M	Buy	29,351 +350	+1%	+$20.5K	0.31%	84
2015 Q4	$1.9M	Sell	29,001 -2,761	-9%	-$171K	0.37%	79
2015 Q3	$1.79M	Sell	31,762 -67,689	-68%	-$4.39M	0.36%	83
2015 Q2	$5.88M	Sell	99,451 -33,976	-25%	-$2.1M	1.05%	29
2015 Q1	$8.31M	Buy	133,427 +2,555	+2%	+$149K	1.52%	13
2014 Q4	$7.53M	Buy	130,872 +1,750	+1%	+$97.5K	1.43%	16
2014 Q3	$6.94M	Sell	129,122 -9,165	-7%	-$486K	1.32%	19
2014 Q2	$7.25M	Buy	138,287 +23,040	+20%	+$1.18M	1.38%	17
2014 Q1	$6.09M	Buy	+115,247	New	+$5.33M	1.22%	22

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Street Advisors's TEVA Position: Q4 2016 in Review

Franklin Street Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 29,001 shares — an estimated $1.33M sold.

Franklin Street Advisors first reported a position in TEVA in Q1 2014 and held it in 11 quarters. The position peaked at $8.31M in Q1 2015. 738 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Franklin Street Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Franklin Street Advisors sold 29,001 Teva Pharmaceuticals shares in Q4 2016, an estimated $1.33M.
Franklin Street Advisors first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 11 quarters.
Franklin Street Advisors's Teva Pharmaceuticals position peaked at $8.31M in Q1 2015.
738 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Franklin Street Advisors's 13F filing for Q4 2016, filed 10 Jan 2017.